This Program Project, currently in its 14th year, has been a leader in the development and application of breast cancer markers, using a highly integrated collaborative approach to develop and test new molecular and cellular markers of breast cancer development and progression. The underlying hypothesis driving this research is that breast cancer is more than one disease at the molecular level, so that characterizing the genetic and molecular properties of each individual tumor will help to predict tumor behavior in individual patients.
Goals Define a realistic probability of recurrence for each patient.
Develop predictors of chemotherapy response. Apply diagnostic and prognostic indicators to premalignant disease. All Rights Reserved.